baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BeiGene Ltd/ US07725L1026 /

2024-04-23 9:59:55 PM	Chg. +8.07	Volume	Bid-	Ask-	High	Low
139.22USD	+6.15%	11,298 Turnover: 1.57 mill.	-Bid Size: -	-Ask Size: -	142.01	135.24

GlobeNewswire 04-11 Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

GlobeNewswire 03-28 SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire 03-28 Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlight...

GlobeNewswire 03-28 Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors

GlobeNewswire 03-27 Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire 03-06 Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire 03-05 Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the ...

GlobeNewswire 02-27 MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor

GlobeNewswire 02-27 SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights ...

GlobeNewswire 02-27 Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire 02-14 Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call

GlobeNewswire 02-08 Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors

GlobeNewswire 01-31 Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire 01-08 SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the ...

GlobeNewswire 01-04 Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025

GlobeNewswire 01-04 Zymeworks Announces Additional Leadership Appointments

GlobeNewswire 2023-12-26 Zymeworks Announces $50 Million Private Placement to EcoR1 Capital

GlobeNewswire 2023-12-15 Zymeworks Added to Nasdaq Biotechnology Index

GlobeNewswire 2023-11-30 Zymeworks Announces Participation in Upcoming Investor Conference

GlobeNewswire 2023-11-07 Zymeworks Provides Corporate Update and Reports Third Quarter 2023 Financial Results

GlobeNewswire 2023-11-07 Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disea...

GlobeNewswire 2023-11-02 SpringWorks Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

GlobeNewswire 2023-11-01 Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire 2023-10-20 NFL HEAD COACH PLEDGES TO PAY FORWARD SUPPORT HE RECEIVED WHEN FACING CANCER DIAGNOSIS

GlobeNewswire 2023-10-17 Zymeworks To Host Third Quarter 2023 Results Conference Call

BeiGene Ltd/ US07725L1026 /

If you wish to receive reply to your feedback, please provide your email address.